Kitty Yale
Corporate Officer/Principal presso AKERO THERAPEUTICS, INC.
Profilo
Kitty Yale is currently the Chief Development Officer at Akero Therapeutics, Inc. Prior to this, she worked at Gilead Sciences, Inc. for 17 years as the Vice President-Clinical Operations.
She also worked at Roche Global Development as a Senior Clinical Research & Operations professional.
Yale received her undergraduate degree from Glasgow Caledonian University.
Posizioni attive di Kitty Yale
| Società | Posizione | Inizio |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2018 |
Precedenti posizioni note di Kitty Yale
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2018 |
| Roche Global Development | Corporate Officer/Principal | - |
Formazione di Kitty Yale
| Glasgow Caledonian University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AKERO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
| Roche Global Development |
- Borsa valori
- Insiders
- Kitty Yale
